Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda
Victor Asua, Melissa D. Conrad, Özkan Aydemir, et al.
The Journal of Infectious Diseases (2020) Vol. 223, Iss. 6, pp. 985-994
Open Access | Times Cited: 166

Showing 1-25 of 166 citing articles:

Evidence of Artemisinin-Resistant Malaria in Africa
Betty Balikagala, Naoyuki Fukuda, Mie Ikeda, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 13, pp. 1163-1171
Open Access | Times Cited: 625
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
Aline Uwimana, Noella Umulisa, Meera Venkatesan, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 8, pp. 1120-1128
Open Access | Times Cited: 325
Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness
Barbara H. Stokes, Satish K. Dhingra, Kelly Rubiano, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 133
Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda
Melissa D. Conrad, Victor Asua, Shreeya Garg, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 8, pp. 722-732
Open Access | Times Cited: 120
Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea
Selam Mihreteab, Lucien Platon, Araia Berhane, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 13, pp. 1191-1202
Open Access | Times Cited: 103
Malaria
Jeanne Rini Poespoprodjo, Nicola Davies, Daniel Ansong, et al.
The Lancet (2023) Vol. 402, Iss. 10419, pp. 2328-2345
Closed Access | Times Cited: 90
Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda
Patrick K. Tumwebaze, Melissa D. Conrad, Martin Okitwi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
Plasmodium falciparum resistance to artemisinin-based combination therapies
Kurt E. Ward, David A. Fidock, Jessica L. Bridgford
Current Opinion in Microbiology (2022) Vol. 69, pp. 102193-102193
Open Access | Times Cited: 70
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa
Philip J. Rosenthal, Victor Asua, Melissa D. Conrad
Nature Reviews Microbiology (2024) Vol. 22, Iss. 6, pp. 373-384
Closed Access | Times Cited: 52
The emergence of artemisinin partial resistance in Africa: how do we respond?
Philip J. Rosenthal, Victor Asua, Jeffrey A. Bailey, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e591-e600
Open Access | Times Cited: 43
Antimalarial Drug Resistance and Implications for the WHO Global Technical Strategy
Matthew M. Ippolito, Kara A. Moser, Jean-Bertin Bukasa Kabuya, et al.
Current Epidemiology Reports (2021) Vol. 8, Iss. 2, pp. 46-62
Open Access | Times Cited: 96
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination
Mehul Dhorda, Chanaki Amaratunga, Arjen M. Dondorp
Current Opinion in Infectious Diseases (2021) Vol. 34, Iss. 5, pp. 432-439
Open Access | Times Cited: 91
Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials
Maëlle Duffey, Benjamin Blasco, Jeremy N. Burrows, et al.
Trends in Parasitology (2021) Vol. 37, Iss. 8, pp. 709-721
Open Access | Times Cited: 86
A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa
Leonard Ndwiga, Kelvin M. Kimenyi, Kevin Wamae, et al.
International Journal for Parasitology Drugs and Drug Resistance (2021) Vol. 16, pp. 155-161
Open Access | Times Cited: 79
Malaria in 2022: Increasing challenges, cautious optimism
Prasanna Jagannathan, Abel Kakuru
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda
Robert Zupko, Tran Dang Nguyen, Jean Claude Semuto Ngabonziza, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2775-2784
Open Access | Times Cited: 25
High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing
Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 10
Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey
Jonathan J. Juliano, David Giesbrecht, Alfred Simkin, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 10, pp. 100920-100920
Open Access | Times Cited: 9
High frequency of artemisinin partial resistance mutations in the Great Lakes region revealed through rapid pooled deep sequencing
Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 9
Artemisinin-resistant malaria
Nicholas J. White, Kesinee Chotivanich
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 9
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024
Martin Okitwi, Stephen Orena, Patrick K. Tumwebaze, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Effectiveness of sulfadoxine–pyrimethamine plus amodiaquine and dihydroartemisinin–piperaquine for seasonal malaria chemoprevention in Uganda: a three-arm, open-label, non-inferiority and superiority, cluster-randomised, controlled trial
Anthony Nuwa, K. Scott Baker, Richard Kajubi, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
Malaria in 2022: Challenges and Progress
Philip J. Rosenthal
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 6, pp. 1565-1567
Open Access | Times Cited: 37
Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990–2020
Jennifer A. Flegg, Georgina Humphreys, Brenda Montanez, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 8, pp. e1010317-e1010317
Open Access | Times Cited: 32
Multiplexed ddPCR-amplicon sequencing reveals isolated Plasmodium falciparum populations amenable to local elimination in Zanzibar, Tanzania
Aurel Holzschuh, Anita Lerch, Inna Gerlovina, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top